Global Veterinary Parasiticides Market Size study, by Type, Animal Type, Formulation, Distribution Channel and Regional Forecasts 2022-2032

Description

Global Veterinary Parasiticides Market is valued approximately at USD 2.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.88% over the forecast period 2024-2032. Veterinary parasiticides have become the frontline defense in modern animal healthcare, targeting both internal and external parasites with scientific precision. These compounds are extensively applied across various animal groups, from pets and livestock to aquaculture and poultry, ensuring not only their health and productivity but also safeguarding the global food supply. The advancement in formulation techniques, along with the surge in awareness regarding zoonotic diseases, is fueling demand for innovative parasiticidal products that are not only potent but also easy to administer across varied animal demographics.

A significant factor propelling the market forward is the rising prevalence of parasitic infections in livestock and companion animals, which in turn impacts economic yields in the livestock industry and quality of life in pets. Moreover, the emergence of combination products that target a broader spectrum of parasites in a single administration is reshaping the industry landscape by offering greater efficacy and improved compliance among animal owners. Furthermore, developments in sustainable and eco-friendly formulations have emerged as a response to the growing regulatory push and environmental concerns, offering alternatives with lower residues and minimal ecological footprint.

Simultaneously, the expansion of global animal farming-especially in developing regions where protein consumption is sharply increasing-is creating new revenue streams for manufacturers. Veterinary parasiticides are no longer viewed solely as therapeutic solutions but are also regarded as preventative health investments, prompting greater integration within herd and flock health programs. Leading pharmaceutical companies are stepping up research efforts, channeling substantial investments toward developing long-acting, species-specific, and resistance-management products. This innovation-driven approach is enhancing treatment outcomes and reducing reinfection cycles, thereby improving animal welfare and productivity on a global scale.

However, challenges continue to loom. The high cost of premium parasiticidal drugs, especially combination and long-acting formulations, is restraining adoption in cost-sensitive markets. In addition, growing concerns over antiparasitic resistance-fueled by overuse and misuse of drugs-are prompting both regulatory bodies and veterinary practitioners to emphasize integrated parasite management approaches. The lack of access to veterinary services in remote and rural regions also remains a critical bottleneck, limiting product reach and awareness.

Regionally, North America continues to hold a commanding share in the veterinary parasiticides market, driven by robust animal health infrastructure, advanced veterinary practices, and high pet ownership rates. Europe follows closely, benefiting from stringent livestock welfare standards and heightened awareness of parasitic zoonoses. Meanwhile, Asia Pacific is poised for the fastest growth over the forecast period, powered by the rapid intensification of animal husbandry, burgeoning companion animal markets in countries like India and China, and improving veterinary care access. Latin America and the Middle East & Africa are gradually emerging as lucrative markets, supported by growing investments in veterinary services and rural livestock development initiatives.

Major market player included in this report are:

Zoetis Inc.
Boehringer Ingelheim International GmbH
Elanco Animal Health Inc.
Merck Animal Health
Virbac
Ceva Sante Animale
Vetoquinol S.A.
Bayer AG
Norbrook Laboratories Ltd.
Dechra Pharmaceuticals PLC
Bimeda Animal Health
Phibro Animal Health Corporation
Ourofino Saude Animal
KRKA, d. d., Novo mesto
Neogen Corporation

The detailed segments and sub-segment of the market are explained below:

By Type

Endoparasiticides
Ectoparasiticides
Combination Products

By Animal Type

Pets
Livestock
Aquaculture
Poultry

By Formulation

Liquids
Powders
Injectables
Tablets

By Distribution Channel

Veterinary Clinics
Retail Pharmacies
E-commerce

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical Year - 2022
Base Year - 2023
Forecast Period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Veterinary Parasiticides Market Executive Summary

1.1. Global Veterinary Parasiticides Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Animal Type
- 1.3.3. By Formulation
- 1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Veterinary Parasiticides Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability of Active Ingredients
  - 2.3.3.2. Manufacturing Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Producer & Consumer)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks & Approvals
  - 2.3.4.2. Technological Advancements in Formulation
  - 2.3.4.3. Environmental & Sustainability Considerations
  - 2.3.4.4. Practitioner & Owner Awareness
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Veterinary Parasiticides Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Parasitic Infections
- 3.1.2. Adoption of Combination and Long-Acting Formulations
- 3.1.3. Integration of Preventive Herd and Flock Health Programs
- 3.1.4. Demand for Eco-Friendly and Low-Residue Solutions
3.2. Market Challenges
- 3.2.1. High Cost of Premium Parasiticides
- 3.2.2. Rising Antiparasitic Resistance
- 3.2.3. Limited Veterinary Access in Rural Regions
- 3.2.4. Regulatory and Reimbursement Barriers
3.3. Market Opportunities
- 3.3.1. Expansion in Emerging Animal Farming Regions
- 3.3.2. Technological Advances in Delivery Systems
- 3.3.3. Growth of E-commerce Distribution Channels
- 3.3.4. Strategic Collaborations and M&A Activities

Chapter 4. Global Veterinary Parasiticides Market Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's Model
- 4.1.7. Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspectives
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Veterinary Parasiticides Market Size & Forecasts by Type (2022-2032)

5.1. Segment Dashboard
5.2. Endoparasiticides Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.3. Ectoparasiticides Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.4. Combination Products Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 6. Global Veterinary Parasiticides Market Size & Forecasts by Animal Type (2022-2032)

6.1. Segment Dashboard
6.2. Pets Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.3. Livestock Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.4. Aquaculture Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.5. Poultry Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 7. Global Veterinary Parasiticides Market Size & Forecasts by Formulation (2022-2032)

7.1. Segment Dashboard
7.2. Liquids Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.3. Powders Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.4. Injectables Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.5. Tablets Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 8. Global Veterinary Parasiticides Market Size & Forecasts by Distribution Channel (2022-2032)

8.1. Segment Dashboard
8.2. Veterinary Clinics Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.3. Retail Pharmacies Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.4. E-commerce Revenue Trend Analysis, 2022 & 2032 (USD Million)

Chapter 9. Global Veterinary Parasiticides Market Size & Forecasts by Region (2022-2032)

9.1. North America
- 9.1.1. U.S. Veterinary Parasiticides Market
  - 9.1.1.1. By Type Breakdown, 2022-2032
  - 9.1.1.2. By Animal Type Breakdown, 2022-2032
  - 9.1.1.3. By Formulation & Channel Breakdown, 2022-2032
- 9.1.2. Canada
9.2. Europe
- 9.2.1. UK
- 9.2.2. Germany
- 9.2.3. France
- 9.2.4. Spain
- 9.2.5. Italy
- 9.2.6. Rest of Europe
9.3. Asia Pacific
- 9.3.1. China
- 9.3.2. India
- 9.3.3. Japan
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Rest of Asia Pacific
9.4. Latin America
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Middle East & Africa
- 9.5.1. Saudi Arabia
- 9.5.2. South Africa
- 9.5.3. Rest of Middle East & Africa

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
- 10.1.1. Zoetis Inc.
- 10.1.2. Boehringer Ingelheim International GmbH
- 10.1.3. Elanco Animal Health Inc.
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Zoetis Inc.
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Merck Animal Health
- 10.3.3. Virbac
- 10.3.4. Ceva Sante Animale
- 10.3.5. Vetoquinol S.A.
- 10.3.6. Bayer AG
- 10.3.7. Norbrook Laboratories Ltd.
- 10.3.8. Dechra Pharmaceuticals PLC
- 10.3.9. Bimeda Animal Health
- 10.3.10. Phibro Animal Health Corporation
- 10.3.11. Ourofino Saude Animal
- 10.3.12. KRKA, d. d., Novo mesto
- 10.3.13. Neogen Corporation

Chapter 11. Research Process

11.1. Research Methodology
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes